Cargando…

Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease

Accumulation and misfolding of the alpha-synuclein protein are core mechanisms in the pathogenesis of Parkinson’s disease. While the normal function of alpha-synuclein is mainly related to the control of vesicular neurotransmission, its pathogenic effects are linked to various cellular functions, wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bobela, Wojciech, Aebischer, Patrick, Schneider, Bernard Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693253/ https://www.ncbi.nlm.nih.gov/pubmed/26501339 http://dx.doi.org/10.3390/biom5042675

Ejemplares similares

Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity
por: Bobela, Wojciech, et al.
Publicado: (2017)

Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2022)

PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein
por: Ciron, Carine, et al.
Publicado: (2015)

S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.
por: Hochhaus, Andreas, et al.
Publicado: (2023)

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
por: Deyell, Jacob S., et al.
Publicado: (2023)

Overexpression of CREMαlpha accelerates onset and severity of auto-immune mediated disease in a murine model of lupus
por: Ohl, Kim, et al.
Publicado: (2011)

Overexpression of CREMαlpha accelerates onset and severity of auto-immune mediated disease in a murine model of lupus
por: Ohl, Kim, et al.
Publicado: (2011)

The transcription factor crem-αlpha regulates inflammatory T cell subsets in juvenile idiopathic arthritis
por: Ohl, Kim, et al.
Publicado: (2014)

Baicalein and Αlpha-Tocopherol Inhibit Toll-like Receptor Pathways in Cisplatin-Induced Nephrotoxicity
por: Awadalla, Amira, et al.
Publicado: (2022)

Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson’s Disease
por: Madsen, Daniel Aghaie, et al.
Publicado: (2021)

Acetylated α-Tubulin and α-Synuclein: Physiological Interplay and Contribution to α-Synuclein Oligomerization
por: Calogero, Alessandra Maria, et al.
Publicado: (2023)

Αlpha 2a-Adrenoceptor Gene Expression and Early Life Stress-Mediated Propensity to Alcohol Drinking in Outbred Rats
por: Comasco, Erika, et al.
Publicado: (2015)

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease
por: Bellucci, Arianna, et al.
Publicado: (2020)

The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease
por: Battis, Kristina, et al.
Publicado: (2023)

Αlpha 5 subunit-containing GABA(A) receptors in temporal lobe epilepsy with normal MRI
por: McGinnity, Colm J, et al.
Publicado: (2021)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease
por: Motyl, Joanna A., et al.
Publicado: (2021)

Endonuclease G mediates α-synuclein cytotoxicity during Parkinson’s disease
por: Büttner, Sabrina, et al.
Publicado: (2013)

The interplay between lipids and dopamine on α-synuclein oligomerization and membrane binding
por: Pham, Chi L. L., et al.
Publicado: (2013)

Interplay between tau and α‐synuclein liquid–liquid phase separation
por: Siegert, Anna, et al.
Publicado: (2021)

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
por: Schneider, Jay S., et al.
Publicado: (2019)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

Non-Cell-Autonomous Neurotoxicity in Parkinson’s Disease Mediated by Astroglial α-Synuclein
por: Chai, MuhChyi, et al.
Publicado: (2019)

C/EBPβ/AEP is age-dependently activated in Parkinson’s disease and mediates α-synuclein in the gut and brain
por: Wang, Hualong, et al.
Publicado: (2023)

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
por: Winslow, Ashley R., et al.
Publicado: (2010)

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
por: Longhena, Francesca, et al.
Publicado: (2017)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
por: Bridi, Jessika C., et al.
Publicado: (2018)

“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
por: Ray, Bipul, et al.
Publicado: (2021)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
por: Tofaris, George K.
Publicado: (2022)

Interaperitoneal Administration of Αlpha-Tocopherol Loaded Nanoparticles Improves Ischemia-Reperfusion Injury in Rat Ovaries Torsion and Detorsion Model
por: Najafpour, Alireza, et al.
Publicado: (2018)

PB2532: VARIABLE HEMATOLOGICAL AND CLINICAL PHENOTYPES IN DOUBLE HETEROZYGOTES OF ΒETA-THALASSEMIA AND TRIPLICATED ΑLPHA-GLOBIN GENES
por: Delaporta, Polyxeni, et al.
Publicado: (2023)

α-synuclein and p53 functional interplay in physiopathological contexts
por: Alves da Costa, Cristine, et al.
Publicado: (2016)

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n7qqhdn2stlp66onijqnbf3iqg